Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia

INTRODUCTION: While allogeneic hematopoietic stem cell transplantation (allo-HSCT) can be a curative regimen for acute myeloid leukemia (AML), relapse of AML remains a serious risk post-transplantation. Once relapsed, salvage options are limited and management of AML is difficult. Here we designed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yimei, Chen, Ting, Zhang, Yun, Yao, Han, Wang, Ping, Wang, Lu, Cassady, Kaniel, Zou, Zhongmin, Liu, Yuqing, Zhao, Lu, Gao, Lei, Zhang, Xi, Kong, Peiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332158/
https://www.ncbi.nlm.nih.gov/pubmed/37435080
http://dx.doi.org/10.3389/fimmu.2023.1182251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332158/
https://www.ncbi.nlm.nih.gov/pubmed/37435080
http://dx.doi.org/10.3389/fimmu.2023.1182251

Ejemplares similares